Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Naltrexone Among Polysubstance Users

NCT01723384 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01723384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Naltrexone Among Polysubstance Users
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
November 30, 2014
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol, methamphetamine